Topic

ERC-2016-COG

ERC-2016-COG

Programme: H2020

315 projects · €613,541,808 total EU contribution (project-level) · 217 participating organizations · 26 countries with participants

Total EU funding

Sum of EC max contribution fields for distinct projects in this topic.

€613,541,808

Countries active

Participant organizations by country (headquarters in CORDIS).

  • Germany (39)
  • UK (38)
  • France (20)
  • Spain (18)
  • Italy (15)
  • Netherlands (15)
  • CH (14)
  • AT (8)
  • BE (8)
  • DK (5)
  • EL (5)
  • PT (5)
  • SE (5)
  • HU (4)
  • IL (3)
  • NO (3)
  • FI (2)
  • IE (2)
  • CZ (1)
  • HR (1)
  • IS (1)
  • LU (1)
  • RS (1)
  • TR (1)
  • US (1)
  • ZA (1)

Open calls

From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.

No open or forthcoming calls linked to this topic in the database yet.

Top organizations

By number of distinct projects in this topic.

Projects

Page 26 of 32

ProjectEU contribution

The Genetics of Morbidity and Survival in Response to Significant Life Stressors

StressGene · 726413

€1,998,544
Details

Elucidating the Role of Enhancer Methylation Variation in Cancer and Developing Enhancer-based Markers and Targets for Precision Medicine

ONCOmetENHANCERS · 724803

€2,000,000
Details

Design of NanoMOFs Capsules for Drug Delivery and Bioimaging.

NanoMOFdeli · 726380

€1,903,685
Details

Spin Transport Beyond Electrons

SPINBEYOND · 725509

€1,617,500
Details

Resolving the molecular mechanisms of intracellular coral-algal symbiosis

SYMCELLS · 724715

€2,272,485
Details

Large-Area Transparent Opto-Electronics using 2D Materials

LATO · 725258

€1,999,318
Details

Design and Engineering Next-Generation Nanopore Devices for Bioplymer Analysis

DeE-Nano · 726151

€1,999,970
Details

Universality in Condensed Matter and Statistical Mechanics

UniCoSM · 724939

€1,235,875
Details

Reticulate evolution: patterns and impacts of non-vertical inheritance in eukaryotic genomes.

RETVOLUTION · 724173

€1,986,178
Details

Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia

ContraNPM1AML · 725725

€1,883,750
Details